Carlsmed, Inc. Market Cap ($408.18 Million)
Market Cap & Net Worth: Carlsmed, Inc. (CARL)
Carlsmed, Inc. market cap. Carlsmed, Inc. (NASDAQ:CARL) has a market capitalization of $408.18 Million ($408.18 Million) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #12955 globally and #3201 in its home market, demonstrating a 2.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Carlsmed, Inc.'s stock price $14.95 by its total outstanding shares 27302743 (27.30 Million). Also see CARL cash generation efficiency for how efficiently the company converts equity into cash flow.
Carlsmed, Inc. Market Cap History (2025–2026)
Carlsmed, Inc. market cap history from 2025 to 2026. Data shows growth from $337.19 Million to $408.18 Million (0.00% CAGR). Check today's stock price for Carlsmed, Inc. for real-time trading data and today's change.
Carlsmed, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Carlsmed, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Carlsmed, Inc. (CARL) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
6.68x
Carlsmed, Inc.'s market cap is 6.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $337.19 Million | $50.51 Million | -$29.63 Million | 6.68x | N/A |
Competitor Companies of CARL by Market Capitalization
Companies near Carlsmed, Inc. in the global market cap rankings as of November 1, 2026. Also see Carlsmed, Inc. balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Carlsmed, Inc. by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of Carlsmed, Inc. (2025–2026)
Market capitalization of Carlsmed, Inc. from 2025 to today. Between 2025 and today, Carlsmed, Inc.'s market cap moved from $337.19 Million to $ 408.18 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $408.18 Million | +21.05% |
| 2025 | $337.19 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Carlsmed, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $408.18 Million USD |
| MoneyControl | $408.18 Million USD |
| MarketWatch | $408.18 Million USD |
| marketcap.company | $408.18 Million USD |
| Reuters | $408.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and … Read more